Genetically modified organisms - medicine
The panel assesses environmental risks from using medicinal products that contain or consist of genetically modified organisms. This is an ongoing assignment for the Norwegian Environment Agency and the Norwegian Medicines Agency.
Monica Sanden (chair)
Assessing risk means assessing how likely it is that a hazard we know leads to injury. In addition, we need to assess how serious the injury is.
VKM is appointed by the Ministry of Health and Care Services. VKM is organized as an independent body, fulfilling the national requirement for independent, transparent and open scientific risk assessments.
Risk assessments in VKM follow current international standards and methodology in the respective fields of responsibility for VKMs panels.